Literature DB >> 18815938

Management of cocaine-induced cardiac arrhythmias due to cardiac ion channel dysfunction.

David M Wood1, Paul I Dargan, Robert S Hoffman.   

Abstract

Cocaine use is common in many areas of the world, particularly the United States and Western Europe. Toxicity following the use of cocaine is associated with a wide range of clinical features. In this review, we will focus on the cocaine-associated cardiac arrhythmias and, in particular, some of the controversies in their etiology and management. Cocaine can produce arrhythmias either through the production of myocardial ischemia or as a direct result of ion channel alterations. Excessive catecholamines, combined with sodium and potassium channel blockades, give rise to a wide variety of supra-ventricular and ventricular rhythms. The animal and human evidence for ion channel dysfunction is reviewed, and the effects of catecholamines are followed from the cardiac action potential to the development of arrhythmias. Finally, theoretical constructs are combined with existing evidence to develop a rational treatment strategy for patients with cocaine-induced cardiac arrhythmias. In particular, we review the evidence concerning the controversies relating to the use of lidocaine in comparison with sodium bicarbonate, in terms of QRS prolongation secondary to sodium channel blockade.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18815938     DOI: 10.1080/15563650802339373

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  13 in total

1.  Putting cocaine use and cocaine-associated cardiac arrhythmias into epidemiological and clinical perspective.

Authors:  David M Wood; Paul I Dargan
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

2.  Cardiac depression induced by cocaine or cocaethylene is alleviated by lipid emulsion more effectively than by sulfobutylether-β-cyclodextrin.

Authors:  Michael R Fettiplace; Adrian Pichurko; Richard Ripper; Bocheng Lin; Katarzyna Kowal; Kinga Lis; David Schwartz; Douglas L Feinstein; Israel Rubinstein; Guy Weinberg
Journal:  Acad Emerg Med       Date:  2015-04-23       Impact factor: 3.451

3.  The effect of olanzapine pretreatment on acute cocaine toxicity in mice.

Authors:  Kennon J Heard; Nathan R Cleveland; Shay Krier
Journal:  Clin Toxicol (Phila)       Date:  2009-07       Impact factor: 4.467

Review 4.  Role of voltage-gated sodium, potassium and calcium channels in the development of cocaine-associated cardiac arrhythmias.

Authors:  Michael E O'Leary; Jules C Hancox
Journal:  Br J Clin Pharmacol       Date:  2010-05       Impact factor: 4.335

5.  Psychostimulant-related deaths among former inmates.

Authors:  Susan Calcaterra; Patrick Blatchford; Peter D Friedmann; Ingrid A Binswanger
Journal:  J Addict Med       Date:  2012-06       Impact factor: 3.702

6.  Accelerated Idioventricular Rhythm Following Intraoral Local Anesthetic Injection During General Anesthesia.

Authors:  Kenichi Sato; Yoshihisa Miyamae; Miwako Kan; Shu Sato; Motoi Yaegashi; Wakana Sakanoue; Hiroyuki Sakai; Souhei Sakamoto; Kazuki Vaba
Journal:  Anesth Prog       Date:  2021-12-01

Review 7.  Sodium acetate as a replacement for sodium bicarbonate in medical toxicology: a review.

Authors:  Mark J Neavyn; Edward W Boyer; Steven B Bird; Kavita M Babu
Journal:  J Med Toxicol       Date:  2013-09

8.  Cocaine Hydrolase Gene Transfer Demonstrates Cardiac Safety and Efficacy against Cocaine-Induced QT Prolongation in Mice.

Authors:  Vishakantha Murthy; Santiago Reyes; Liyi Geng; Yang Gao; Stephen Brimijoin
Journal:  J Pharmacol Exp Ther       Date:  2015-12-15       Impact factor: 4.030

Review 9.  Antidotes for childhood toxidromes.

Authors:  Kam Lun Hon; Wun Fung Hui; Alexander Kc Leung
Journal:  Drugs Context       Date:  2021-06-02

Review 10.  Cardiovascular and Hepatic Toxicity of Cocaine: Potential Beneficial Effects of Modulators of Oxidative Stress.

Authors:  Manuela Graziani; Letizia Antonilli; Anna Rita Togna; Maria Caterina Grassi; Aldo Badiani; Luciano Saso
Journal:  Oxid Med Cell Longev       Date:  2015-12-28       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.